Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure

 and comment on whether the rule should be adjusted due to the new statutory provisions. The Department chose to draw the public's attention to the CAA, 2026 and specifically seek comments on the interaction with the proposal to ensure robust public input on that matter. Commenters had notice and a full opportunity to submit comments on the interaction with the CAA, 2026, including the statutory authority, as evidenced by the substantial volume of [[Page 69146]] comments addressing precisely these issues. 14.2. Placement This final rule, establishing disclosure requirements for covered service providers to covered plans, will appear at 29 CFR 2550.408b-22. In connection with this final rule, the Department is also revising its existing service provider regulation (29 CFR 2550.408b-2(c)(2)) in the Code of Federal Regulations to cross-reference the final rule. 15. Severability The Department proposed under paragraph (o) that if any provision of the rule is held to be invalid or unenforceable by its terms, or as applied to any person or circumstance, or stayed pending further agency action, the provision shall be construed so as to continue to give the maximum effect to the provision permitted by law, unless such holding shall be one of invalidity or unenforceability, in which event the provision shall be severable from this section and shall not affect the remainder thereof. The